Table 1 Clinical characteristics of patients with cardiac myxoma
From: Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression
Asymptomatic (n = 11) | Mild (n = 31) | Severe (n = 8) | P value | |
|---|---|---|---|---|
Sex | ||||
Female | 8 (72.7%) | 23 (74.2%) | 6 (75%) | 1 |
Male | 3 (27.3%) | 8 (25.8%) | 2 (25%) | |
Age | ||||
<55 | 4 (36.4%) | 17 (54.8%) | 4 (50%) | 0.615 |
≥55 | 7 (63.6%) | 14 (45.2%) | 4 (50%) | |
Hypertension | ||||
No | 7 (63.6%) | 28 (90.3%) | 6 (75%) | 0.104 |
Yes | 4 (36.4%) | 3 (9.7%) | 2 (25%) | |
Smoking | ||||
No | 9 (81.8%) | 26 (83.9%) | 6 (75%) | 0.871 |
Yes | 2 (18.2%) | 5 (16.1%) | 2 (25%) | |
Sizea | ||||
<1500 mm2 | 7 (70%) | 22 (71%) | 8 (100%) | 0.268 |
≥1500 mm2 | 3 (30%) | 9 (29%) | 0 (0%) | |
Location | ||||
Left atrium | 10 (90.9%) | 26 (83.9%) | 8 (100%) | 0.884 |
Right atrium | 1 (9.1%) | 4 (12.9%) | 0 (0%) | |
Others | 0 (0%) | 1 (3.2%) | 0 (0%) | |
Mobilitya | ||||
Low | 5 (50%) | 9 (29%) | 1 (12.5%) | 0.268 |
High | 5 (50%) | 22 (71%) | 7 (87.5%) | |
Blockagea | ||||
No | 7 (70%) | 17 (54.8%) | 5 (62.5%) | 0.77 |
Yes | 3 (30%) | 14 (45.2%) | 3 (37.5%) | |
